1990-2017年中国宫颈癌的发病率分析(2)
参考文献
[1]Wang，S.M.and Y.L.Qiao (2015)."Implementation of cervical cancer screening and prevention in China--challenges and reality." Jpn J Clin Oncol 45(1)： 7-11.
[2]Torre LA，Islami F，Siegel RL，Ward EM，Jemal A.Global Cancer in Women： Burden and Trends. Cancer Epidemiol Biomark Prev，2017;26：444-457.
[3]Shrestha， A. D.， et al. (2018). "Cervical Cancer Prevalence， Incidence and Mortality in Low and Middle Income Countries： A Systematic Review." Asian Pac J Cancer Prev 19(2)： 319-324
[4]Wei M，Zhou W，Bi Y，Wang H，Liu Y，Zhang ZJ，Rising Mortality Rate of Cervical Cancer in Younger Women in Urban China.J Gen Intern Med，2019;34：281-284.
[5]Screening，P.D.Q.and B.Prevention Editorial(2002).Cervical Cancer Screening (PDQ(R))：Health Professional Version.PDQ Cancer Information Summaries.Bethesda (MD)，National Cancer Institute (US).
[6]Hillemanns，P.，et al.(2016). "Epidemiology and Early Detection of Cervical Cancer."Oncol Res Treat 39(9)：501-506.
[7]Qiao YL，Sellors JW，Eder PS，et al.A new HPV-DNA test for cervicalcancer screening in developing regions： a cross-sectional study of clinical accuracy in rural China. Lancet Oncol， 2008;9：929-936.
[8]Garcia-Carrasco，M.，et al.(2019)."Prevalence of cervical HPV infection in women with systemic lupus erythematosus： A systematic review and meta-analysis."Autoimmun Rev 18(2)：184-191.
[9]Cohen，P.A.，et al.(2019)."Cervical cancer."Lancet 393(10167)： 169-182.
[10]Garland， S. M. and D. R. Brown (2014). "Potential of the quadrivalent human papillomavirus vaccine in the prevention and treatment of cervical cancer." Expert Opin Biol Ther 14(4)：527-534.
作者簡介
陈彤(1995-)，女，湖南省岳阳县人。硕士学位。主要研究方向为公共卫生。, 百拇医药
[1]Wang，S.M.and Y.L.Qiao (2015)."Implementation of cervical cancer screening and prevention in China--challenges and reality." Jpn J Clin Oncol 45(1)： 7-11.
[2]Torre LA，Islami F，Siegel RL，Ward EM，Jemal A.Global Cancer in Women： Burden and Trends. Cancer Epidemiol Biomark Prev，2017;26：444-457.
[3]Shrestha， A. D.， et al. (2018). "Cervical Cancer Prevalence， Incidence and Mortality in Low and Middle Income Countries： A Systematic Review." Asian Pac J Cancer Prev 19(2)： 319-324
[4]Wei M，Zhou W，Bi Y，Wang H，Liu Y，Zhang ZJ，Rising Mortality Rate of Cervical Cancer in Younger Women in Urban China.J Gen Intern Med，2019;34：281-284.
[5]Screening，P.D.Q.and B.Prevention Editorial(2002).Cervical Cancer Screening (PDQ(R))：Health Professional Version.PDQ Cancer Information Summaries.Bethesda (MD)，National Cancer Institute (US).
[6]Hillemanns，P.，et al.(2016). "Epidemiology and Early Detection of Cervical Cancer."Oncol Res Treat 39(9)：501-506.
[7]Qiao YL，Sellors JW，Eder PS，et al.A new HPV-DNA test for cervicalcancer screening in developing regions： a cross-sectional study of clinical accuracy in rural China. Lancet Oncol， 2008;9：929-936.
[8]Garcia-Carrasco，M.，et al.(2019)."Prevalence of cervical HPV infection in women with systemic lupus erythematosus： A systematic review and meta-analysis."Autoimmun Rev 18(2)：184-191.
[9]Cohen，P.A.，et al.(2019)."Cervical cancer."Lancet 393(10167)： 169-182.
[10]Garland， S. M. and D. R. Brown (2014). "Potential of the quadrivalent human papillomavirus vaccine in the prevention and treatment of cervical cancer." Expert Opin Biol Ther 14(4)：527-534.
作者簡介
陈彤(1995-)，女，湖南省岳阳县人。硕士学位。主要研究方向为公共卫生。, 百拇医药